Join our 2025 QBD-roadshow for startups and scale-ups in Pharma & MedTech
Free
Bringing a MedTech or Pharma product to market can be challenging—especially for startups and scale-ups. From securing intellectual property, defining the right market strategy to navigating the regulatory landscape, early-stage companies face unique challenges that can slow down innovation and market entry.
That's why QbD Group, a trusted partner in life sciences and healthcare industries and Gevers, a leading intellectual property firm, have joined forces to organize an exclusive roadshow across Belgium, designed specifically for startups and scale-ups.
What can you expect?
Get ready for an inspiring lineup of speakers who will expertly guide you through the complex IP and regulatory landscape of Pharma and MedTech.
At each stop of the roadshow, you’ll receive the same valuable insights—packed with practical tips, expert advice, and real-world examples. Whether you're in Biotech or MedTech, this event is designed to help you tackle common challenges that come with running a startup or scale-up. Unlock early value for your company and fast-track your path to market. Don’t miss it!
What's in it for you?
- Gain insights from our extensive experience in Pharma and MedTech
- Discover key challenges and often-overlooked opportunities
- Learn practical strategies to overcome industry hurdles
- Get expert tips and real-world examples
- Maximize your company’s value
- Accelerate your path to market
- Connect with industry experts & expand your network
The dates of our roadshow
- Liège - LégiaPark
25th September 2025 at 12 PM - Diepenbeek - BioVille
23rd October 2025 at 12 PM
Organiser
QbD Group

Related Events
How can we help?
The Leuven MindGate team is at your disposal for any questions about the Leuven Innovation Region. Do you want to invest, work or study in the region? We can help you find your way.
We also facilitate collaboration and innovation between companies, knowledge institutes and government within the Leuven Innovation Region, and we are happy to guide any of these stakeholders towards innovation.